FDA Places PC14586, for Cancers with Mutant Protein, on Fast Track
News
The U.S. Food and Drug Administration (FDA) has granted fast track designation to PC14586 as a potential treatment of advanced cancers that harbor a specific mutation affecting the protein p53, ... Read more